SCHEMBL1646836

SCHEMBL1646836

COc1ccccc1NC1CCC1

nearest known ligand 0.57

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.55
▸ NPSR1 Q6W5P4 1/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.50
▸ DRD2 P14416 1/20 0.50
▸ HPGD P15428 3/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ GAA P10253 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ NPC1 O15118 1/20 0.48
▸ TP53 P04637 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ TRPM8 Q7Z2W7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19915073 0.95 NPSR1 (0.61) LMNANPSR1SMN1; SMN2DRD2HPGD
SCHEMBL1645759 0.92 DRD2 (0.52) LMNANPSR1SMN1; SMN2DRD2RAB9A
SCHEMBL1673520 0.84 HTR2C (0.54) LMNANPSR1SMN1; SMN2DRD2ALDH1A1
SCHEMBL2090904 0.84 RAB9A (0.49) LMNANPSR1SMN1; SMN2DRD2HPGD
Hydrochloric Acid SCHEMBL15819292 0.83 HTR2C (0.55) LMNANPSR1SMN1; SMN2DRD2MAPT
SCHEMBL6887466 0.81 HTR3A (0.66) LMNANPSR1SMN1; SMN2DRD2MAPT
SCHEMBL6890751 0.81 HTR3A (0.66) LMNANPSR1SMN1; SMN2DRD2MAPT
SCHEMBL6813677 0.81 ALDH1A1 (0.58) LMNASMN1; SMN2TSHRKDM4EGAA
SCHEMBL7478390 0.80 MAPT (0.43) LMNANPSR1SMN1; SMN2DRD2RAB9A
SCHEMBL20931339 0.78 KDM4E (0.54) LMNANPSR1SMN1; SMN2HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4665239-B2 — — 2011-04-06 — — JP claimed
JP-2002512230-A — — 2002-04-23 — — JP claimed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 — — EP claimed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 — — WO claimed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 — — EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 — — WO disclosed
Send feedback